These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34286403)

  • 1. Did the COVID-19 pandemic change the willingness to pay for an early warning system for infectious diseases in Europe?
    Himmler S; van Exel J; Brouwer W
    Eur J Health Econ; 2022 Feb; 23(1):81-94. PubMed ID: 34286403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Willingness to pay for health gains from an international integrated early warning system for infectious disease outbreaks.
    Perry-Duxbury M; Himmler S; van Exel J; Brouwer W
    Eur J Health Econ; 2023 Aug; 24(6):967-986. PubMed ID: 36169765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Willingness to pay for an early warning system for infectious diseases.
    Himmler S; van Exel J; Perry-Duxbury M; Brouwer W
    Eur J Health Econ; 2020 Jul; 21(5):763-773. PubMed ID: 32180067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Willingness to pay for SARS-CoV-2 rapid antigen tests during the COVID-19 pandemic: evidence from the general adult population.
    Hajek A; König HH
    Public Health; 2022 Jun; 207():19-23. PubMed ID: 35483163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of the COVID-19 Pandemic on Tourists' WTP: Using the Contingent Valuation Method.
    Jeon CY; Yang HW
    Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Willingness to pay for COVID-19 vaccines: Applying the health belief model.
    Arabyat RM; Nusair MB; Al-Azzam SI; Amawi HA; El-Hajji FD
    Res Social Adm Pharm; 2023 Jan; 19(1):95-101. PubMed ID: 36153237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of COVID-19 tests in Latin America.
    Trudeau JM; Alicea-Planas J; Vásquez WF
    Econ Hum Biol; 2020 Dec; 39():100931. PubMed ID: 33126025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Progress in the practice of surveillance and early warning of infectious diseases in major countries and regions].
    Huang S; Liu CX; Deng Y; Zhang CH; Fan SM; Zheng JD; Wang LP
    Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Apr; 43(4):591-597. PubMed ID: 35443318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Summary and prospect of early warning models and systems for infectious disease outbreaks].
    Lai SJ; Feng LZ; Leng ZW; Lyu X; Li RY; Yin L; Luo W; Li ZJ; Lan YJ; Yang WZ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Aug; 42(8):1330-1335. PubMed ID: 34404153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Willingness-to-pay for a COVID-19 vaccine and its associated determinants in Indonesia.
    Harapan H; Wagner AL; Yufika A; Winardi W; Anwar S; Gan AK; Setiawan AM; Rajamoorthy Y; Sofyan H; Vo TQ; Hadisoemarto PF; Müller R; Groneberg DA; Mudatsir M
    Hum Vaccin Immunother; 2020 Dec; 16(12):3074-3080. PubMed ID: 32991230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Willingness to Pay for a COVID-19 Vaccine.
    Cerda AA; García LY
    Appl Health Econ Health Policy; 2021 May; 19(3):343-351. PubMed ID: 33619688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 40 health systems, COVID-19 (40HS, C-19) study.
    Braithwaite J; Tran Y; Ellis LA; Westbrook J
    Int J Qual Health Care; 2021 Feb; 33(1):. PubMed ID: 32991713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On willingness to pay for Covid-19 vaccines: a case study from India.
    Das U; Rathore U; Pal R
    Hum Vaccin Immunother; 2021 Dec; 17(12):4904-4913. PubMed ID: 34757868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficiency in the governance of the Covid-19 pandemic: political and territorial factors.
    Martínez-Córdoba PJ; Benito B; García-Sánchez IM
    Global Health; 2021 Sep; 17(1):113. PubMed ID: 34548073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants and Willingness to Pay for Purchasing Mask against COVID-19: A Protection Motivation Theory Perspective.
    Ding Q; Lin S; Wang S
    Int J Environ Res Public Health; 2022 Apr; 19(7):. PubMed ID: 35409947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early warnings of COVID-19 outbreaks across Europe from social media.
    Lopreite M; Panzarasa P; Puliga M; Riccaboni M
    Sci Rep; 2021 Jan; 11(1):2147. PubMed ID: 33495534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Willingness to pay to enhance pandemic preparedness in Mauritius.
    Jeetoo J; Jaunky VC; Imhof JO
    Public Health; 2022 Oct; 211():144-148. PubMed ID: 36113200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What matters: non-pharmaceutical interventions for COVID-19 in Europe.
    Liu Y; Yu Q; Wen H; Shi F; Wang F; Zhao Y; Hong Q; Yu C
    Antimicrob Resist Infect Control; 2022 Jan; 11(1):3. PubMed ID: 35000583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The perfection of the law on prevention and treatment of infectious diseases against the backdrop of COVID-19 pandemic].
    Wang CL
    Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Feb; 55(2):167-170. PubMed ID: 34645174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential long-term impact of the COVID-19 outbreak on patients with non-communicable diseases in Europe: consequences for healthy ageing.
    Palmer K; Monaco A; Kivipelto M; Onder G; Maggi S; Michel JP; Prieto R; Sykara G; Donde S
    Aging Clin Exp Res; 2020 Jul; 32(7):1189-1194. PubMed ID: 32458356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.